Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience

Capturing patient experience: a qualitative study of change from NAFLD to MAFLD real-time feedback

(2021) Shereen Abdel Alem et al.   JOURNAL OF HEPATOLOGY

From NAFLD to MAFLD: nurse and allied health perspective

(2021) Michelle Clayton et al.   LIVER INTERNATIONAL

Change from NAFLD to MAFLD increases the awareness of fatty liver disease in primary care physicians and specialists

(2021) Yasser Fouad et al.   JOURNAL OF HEPATOLOGY

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   GASTROENTEROLOGY

Looking into a new era for the approach of metabolic (dysfunction) associated fatty liver disease

(2020) Alejandro Valencia-Rodríguez et al.   Annals of Hepatology

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Redefining fatty liver disease: an international patient perspective

(2020) Gamal Shiha et al.   Lancet Gastroenterology & Hepatology

The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease

(2020) Nahum Mendez-Sanchez et al.   Lancet Gastroenterology & Hepatology

Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission

(2019) Shiv K Sarin et al.   Lancet Gastroenterology & Hepatology

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology